Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate 31722-0185-01
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 29, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA214959
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 1.25 mg/1 |
| Amphetamine Sulfate | 1.25 mg/1 |
| Dextroamphetamine Saccharate | 1.25 mg/1 |
| Dextroamphetamine Sulfate | 1.25 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Selected Package
31722-0185-01Selected100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-185-01)